Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes

S Urien1

  • 1Laboratoire de Pharmacologie, Faculté de Médecine, Université Paris XII, Créteil, France.

Pharmaceutical Research
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP.

Cancer chemotherapy and pharmacology·2019
Same author

Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis.

Anaesthesia·2018
Same author

Pre-transplant donor CD4<sup>-</sup> invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Leukemia·2016
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer.

Cancer chemotherapy and pharmacology·2014

MicroPharm-K (MP-K) is a user-friendly pharmacokinetic modeling program for PC computers. It effectively analyzes experimental data, estimates parameters, and simulates results, proving useful for research and education.

Area of Science:

  • Pharmacokinetics
  • Computational Biology
  • Biomedical Software

Background:

  • Pharmacokinetic (PK) modeling is crucial for understanding drug behavior in the body.
  • Existing software may lack user-friendliness or specific functionalities for PK analysis.
  • There is a need for accessible tools for PK data analysis and simulation.

Purpose of the Study:

  • To develop MicroPharm-K (MP-K), an interactive, user-friendly microcomputer program for pharmacokinetic modeling.
  • To enable analysis of experimental data, estimation of PK parameters, and simulation of drug disposition.
  • To provide an accessible tool for researchers and educators on standard PC computers.

Main Methods:

  • MP-K utilizes a library of predefined models for various administration routes (oral, intravenous) and compartmental structures (1-3 compartments).

Related Experiment Videos

  • The program supports single and multiple drug administrations.
  • Non-linear model fitting employs algorithms like Simplex, Evol, Gauss-Newton, Levenberg-Marquardt, or Fletcher-Powell, based on maximum likelihood estimation and weighted or extended least squares.

    • Main Results:

    • MP-K provides immediate graphical representations of raw and fitted data, including log-scale plots.
    • Key pharmacokinetic parameters such as area under the curve (AUC), clearance, and volumes of distribution are readily calculated.
    • Analysis of simulated and experimental data yielded results comparable to those from other established PK software.

    Conclusions:

    • MicroPharm-K (MP-K) is a highly effective software package for pharmacokinetic studies, encompassing parameter estimation and simulation.
    • Its ease of use and ability to run on basic computers make it suitable for educational purposes in pharmacokinetics.
    • The program facilitates efficient pharmacokinetic data analysis and modeling.